9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one has been researched along with Osteoarthritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
He, L; Jia, Y; Peng, J; Qian, Y; Sun, P; Wang, Y; Yang, Q; Yang, W; Zhang, T; Zhao, K | 1 |
1 other study(ies) available for 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Osteoarthritis
Article | Year |
---|---|
Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Disease Models, Animal; Furocoumarins; Interleukin-1beta; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha | 2020 |